Clinical & Diagnostic
Primo Biotechnology Secures PIC/S GMP and GDP Certifications, Strengthening Global Position in Nuclear Medicine
Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...
April 25, 2025 | News
Sun Pharma and Moebius Medical Showcase Durable Pain Relief and Cartilage Protection with MM-II for Knee Osteoarthritis
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New d...
April 25, 2025 | News
Doer Bio Begins Phase 2 Trial of Tri-Agonist DR10624 for MASLD and MASH Treatment
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...
April 24, 2025 | News
GHIT Fund Commits USD 4.6 Million to Tackle TB and Neglected Diseases in Low- and Middle-Income Regions
The Global Health Innovative Technology (GHIT) Fund announced an investment of approximately JPY 679 million (USD 4.5 million) for the...
April 23, 2025 | News
Clarity Pharmaceuticals Secures Commercial-Scale Copper-64 Supply Agreement with Nusano Ahead of U.S. Product Launch
Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 squa...
April 18, 2025 | News
Fangzhou Launches AI-Driven Hepatitis Training Center with Guangdong Institute at Liver Disease Forum 2025
Fangzhou Inc., a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the 2025 Greater Bay Area Int...
April 17, 2025 | News
Clarity Begins Phase II Dosing in SECuRE Trial for Prostate Cancer with Enhanced 67Cu-SAR-bisPSMA Formulation
The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GB...
April 16, 2025 | News
XellSmart Receives IND Approval from FDA for iPSC-Derived Cell Therapy in Parkinson’s Disease
In January 2025 (U.S. time), the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submi...
April 16, 2025 | News
Bristol Myers Squibb’s Opdivo Plus Yervoy Wins FDA Nod as First-Line Treatment for Advanced Liver Cancer
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo® (nivolumab) plus Yervoy® ...
April 14, 2025 | News
GPC-100, a CXCR4 Inhibitor, Moves Toward AML Trials Following Promising Preclinical and Phase 1 Data; Phase 2 in Multiple Myeloma Ongoing
Exicure, Inc. shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning f...
April 14, 2025 | News
Halozyme and argenx Secure FDA Nod for VYVGART® Hytrulo Prefilled Syringe for Self-Injection
Halozyme Therapeutics, Inc. announced that argenx has received U.S. Food and Drug Administration (FDA) approval of VYVGART® Hytrulo prefilled syri...
April 11, 2025 | News
Lucence and HKPOS Launch Hong Kong’s First Study on Blood Test for Early Lung Cancer Detection
In a two-year collaboration with HKPOS, 600 lung cancer patients aged 45-74 in Hong Kong will be studied using Lucence's non-invasive liquid biopsy to as...
April 10, 2025 | News
Darnatein Secures First International Patent in China for AI-Engineered Osteoarthritis Drug Technology
Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international pat...
April 10, 2025 | News
China’s AIM Vaccine Set to Launch World’s First Serum-Free Rabies Vaccine Following Regulatory Acceptance
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced on April 7, 2025 that the company's research and development of the se...
April 08, 2025 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
